Takehito Yogo

Shanghai Nissho Vacuum Flask Refill Co., Ltd. engages in the manufacture and sale of vacuum flasks. The firm also offers ampoules, test tubes, vials, thermos, and other glass products. The company was founded on December 15, 1995 and is headquartered in Shanghai, China.

Celesta Global Capital Managers LLC (Celesta Capital) is a venture capital firm founded in 2013 by Michael Marks, Nicholas Brathwaite, Sriram Viswanathan and Lip-Bu Tan. The firm is headquartered in San Francisco, California.

Founded by Michael E. Marks in 2008, Riverwood Capital LLC is a private equity firm located in Menlo Park, California

Riverwood Capital Management LP (Riverwood Capital) is a private equity firm founded in 2007 by Francisco Alvarez-Demalde and Jeff Parks. The firm is headquartered in Menlo Park, California.

NIPRO Medical Corp. engages in the manufacture of renal, medical-surgical, and interventional radiology products. Its products include dialyzer, blood tubing sets. Fistula needles, hypodermic syringes, ancillaries, hypodermic needles and syringes, IV catheters, infusion needles, and blood collection needles. The company was founded in 1996 and is headquartered in Miami, FL.

Katerra, Inc. provides buildings design and project management services. Its products include building platform, structural systems, mass timber and windows. The firm offers end-to-new build, construction and renovation services. The company was founded by Michael E. Marks, James A. Davidson and Fritz H. Wolff in 2015 and is headquartered in Menlo Park, CA.

Nipro Pharma Corp. manufactures and distributes pharmaceutical products. The firm involves in producing contract pharmaceutical products in all dosage forms, including injectables, orally administered drugs, and external preparations. The company was founded on August 1, 1948 and is headquartered in Osaka, Japan.

Part of Nipro Corp., Nipro Asia Pte Ltd. is a leader in renal care, providing cutting-edge solutions for hemodialysis and dialysis-related treatments for over 50 years. The company is based in Singapore, Singapore. The Singaporean company offers a synthetic hollow-fiber dialyzer called Elisio™, which has a unique polynephron membrane that delivers outstanding performance, excellent biocompatibility, and low thrombogenicity. Nipro Asia also provides trusted medical devices and pharmaceuticals. Seigo Tsuchiya has been the CEO of the company since 2007.

Onx, Inc. is a company that merges high-end design and leading technology to create beautiful homes that are built to last and built for joy. The company is based in Carrollton, TX. The company's tools are science and technology, and they implement new methods and robotics to usher in a new era of precision housing.

Flextronics Corp. provides fiberoptics and electronics manufacturing services. The company is located in Westford, MA.

Part of Nipro Corp., Shenyang Medical Source Dialysis Center Co., Ltd. is a company that operates dialysis centers. The company is based in Shenyang, China. Shenyang Medical Source Dialysis Center Co. was acquired by Nipro Trading (Shanghai) Co., Ltd. on April 26, 2021. The Chinese company was founded in 2017.

Teak Technologies, Inc. provides theoretically integrated interconnect solutions for networks and applications. It is a systems solutions company which provides blade servers. The company was founded by Konda Venkat and is headquartered in Santa Clara, CA.

Part of Nipro Corp., Nipro (Changsha) Hemodialysis Co., Ltd. is a Chinese company that operates dialysis centers. The company is based in Changsha, China. The company was founded in 2019. The CEO is Gui Geng Tang.

Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan.

Japanese Chamber of Commerce Industry of New York, Inc. is non-profit organization that engages in facilitation of trade between the U.S. and Japan. The company was founded on November 14, 1932 by 14 prominent Japanese businessman, and is headquartered in New York, NY.

Part of Nipro Corp., Nipro (Thailand) Corp. Ltd. is a company that manufactures surgical and medical instruments. The company is based in Ayutthaya, Thailand.

Part of ITOCHU Corp., A2 Healthcare Corp. provides clinical development support. The company is based in Tokyo, Japan.

Cloudian Holdings, Inc. engages in the development and provision of software data storage services. The company was founded in 2013 and is headquartered in San Mateo, CA.

ROYAL GATE, Inc. provides information technology (IT) solutions and consulting services. It operates through the following divisions: IT Solutions, ASP and IT Consulting. The IT Solutions division provides system development, website creation, design production, social networking service customization, EC systems customization, search engine optimization and marketing support. The ASP division provides PAYGATE (smart phone type credit card reader service) and COdeGATE (tablet smart phone and corresponding multi-settlement services). The IT Consulting division handles the IT business strategy planning; IT advisory services; and systems development, testing, and maintenance. The company was founded by Keiji Umemura on September 12, 2007 and is headquartered in Tokyo, Japan.

SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe.

PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan.

NapaJen Pharma, Inc. develops drug delivery technology solutions through cellular transport pathways. Its products include lead platform and drug delivery. The firm specializes in the development of novel drug delivery systems by utilizing natural transport pathways whose cells are used to move molecular cargo into themselves and across internal compartments. The company was founded by Dr. Kazuo Sakurai and Hironori Ando in December 2004 and is headquartered in Burlingame, CA.

The Innovation Network Corporation of Japan (INCJ), a unique public-private partnership aimed at promoting innovation and enhancing the value of businesses in Japan, was launched in July 2009. Leveraging the rich history of Japanese technological prowess, the INCJ aims to provide financial, technological and management support in order to promote the creation of next-generation businesses through 'open innovation,' or the flow of technology and expertise beyond the boundaries of existing organizational structures. The INCJ will draw on funding as well as management and technological expertise from the public and private sectors. The INCJ is actively reviewing various investment opportunities in areas of environment and energy, electronics and IT, bio-tech, and infrastructure such as water supply, railway service, and nuclear power supply. Each investment will be thoroughly vetted to ensure it meets the exacting standards of the INCJ's Innovation Network Committee, which will make the final investment decisions. The INCJ is capitalized at 92 billion yen, with the Japanese government injecting 82 billion yen and 19 private corporations (refer to details in Appendix below) providing a further 10 billion yen. The government will also provide guarantees up to a total of 800 billion yen for INCJ investments, giving it an investment capability of approximately 900 billion yen (US$10 billion). The INCJ will be established for a period of 15 years.

KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.

TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB.